New pricing agreement in France includes provisions on biosimilars pricing for the first time.

Published date25 March 2021
Subject MatterBiosimilars,France,Drug Pricing,Pharmaceutical Industry
Law FirmAllen & Overy LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT